Heterogeneous distribution of EGFR mutation in NSCLC: Case report

[1]  J. Tost,et al.  Pyrosequencing , 2020, Definitions.

[2]  Jin-Ji Yang,et al.  Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level , 2019, BMC Cancer.

[3]  M. Maemondo,et al.  Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing. , 2019, Future oncology.

[4]  Junling Li,et al.  Clinicopathologic characteristics and outcome of patients with different EGFR mutations , 2018, Asia-Pacific journal of clinical oncology.

[5]  Jialei Wang,et al.  Response to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma with the Rare Epidermal Growth Factor Receptor Mutation S768I: a Retrospective Analysis and Literature Review , 2017, Targeted oncology.

[6]  Lisa M Haley,et al.  Heterogeneity of resistance mutations detectable by next-generation sequencing in TKI-treated lung adenocarcinoma , 2016, Oncotarget.

[7]  Baorui Liu,et al.  EGFR-tyrosine kinase inhibitor treatment in a patient with advanced non-small cell lung cancer and concurrent exon 19 and 21 EGFR mutations: A case report and review of the literature. , 2016, Oncology letters.

[8]  G. Botti,et al.  Correction: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma , 2015, PloS one.

[9]  M. Fassan,et al.  Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma , 2015, Oncotarget.

[10]  N. McGranahan,et al.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.

[11]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[12]  P. Laurent-Puig,et al.  Intratumoral distribution of EGFR mutations and copy number in metastatic lung cancer, what impact on the initial molecular diagnosis? , 2014, Journal of Translational Medicine.

[13]  C. Capella,et al.  Pyrosequencing for EGFR Mutation Detection: Diagnostic Accuracy and Clinical Implications , 2013, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[14]  A. Warth,et al.  Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies , 2012, Virchows Archiv.

[15]  J. Sørensen,et al.  Intratumor heterogeneity and chemotherapy-induced changes in EGFR status in non-small cell lung cancer , 2012, Cancer Chemotherapy and Pharmacology.

[16]  K. Matsuo,et al.  Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Lantuejoul,et al.  Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC , 2011, Journal of experimental & clinical cancer research : CR.

[18]  Kaoru Irisa,et al.  Good clinical response to gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC > ATC in exon 20 (S768I). , 2010, Japanese journal of clinical oncology.

[19]  M. Saegusa,et al.  EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance , 2008, International journal of cancer.

[20]  Kikuya Kato,et al.  Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib , 2008, Cancer science.

[21]  M. Tsao,et al.  Tissue Heterogeneity of EGFR Mutation in Lung Adenocarcinoma , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  James R. Knight,et al.  Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.

[23]  Xuan Pan,et al.  Response to EGFR-TKI in patients with gastrointestinal metastasis from primary lung adenocarcinoma : report of two cases , 2016 .